health
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop ...

BEIJING, Sept. 24, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company has entered into a strategic research collaboration and license...
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

Moody? Aggressive? You could have ‘irritable male syndrome’
New York Post

Ozempic and Wegovy linked to brain health risks from caloric cuts
Fox News

After 20 Miscarriages, Mom Celebrates Son’s First Birthday: ‘I Couldn’t Give Up’ (Exclusive)
Yahoo

5 Georgia siblings diagnosed with measles
WSB-TV

People Who Drink Their Own Pee Are Obsessed With AI, Using It to Reassure Themselves That It's a Miraculous Cure-All
Futurism